Johnson & Johnson (JNJ)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 167,558,000 166,061,000 191,686,000 195,969,000 187,378,000 175,124,000 177,724,000 178,355,000 182,018,000 179,228,000 176,440,000 172,557,000 174,894,000 170,693,000 158,380,000 155,017,000 157,728,000 155,521,000 155,117,000 150,027,000
Total stockholders’ equity US$ in thousands 68,774,000 71,228,000 75,149,000 70,869,000 76,804,000 74,599,000 76,357,000 74,709,000 74,023,000 70,272,000 69,580,000 65,834,000 63,278,000 64,473,000 62,978,000 61,294,000 59,471,000 58,210,000 60,785,000 58,955,000
Financial leverage ratio 2.44 2.33 2.55 2.77 2.44 2.35 2.33 2.39 2.46 2.55 2.54 2.62 2.76 2.65 2.51 2.53 2.65 2.67 2.55 2.54

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $167,558,000K ÷ $68,774,000K
= 2.44

The financial leverage ratio for Johnson & Johnson has exhibited fluctuations over the past eight quarters, ranging from 2.33 to 2.77. The ratio indicates that, on average, the company relies on debt to finance its assets at a level of approximately 2.44 times.

A high financial leverage ratio suggests that a company is using a higher level of debt in its capital structure, which can amplify returns on equity when operating income is greater than the cost of debt. However, it also indicates a higher financial risk and vulnerability to economic downturns or interest rate increases.

The downward trend in the financial leverage ratio from Q1 2023 to Q3 2023 followed by an increase in Q4 2023 indicates fluctuations in Johnson & Johnson's debt levels relative to its equity during these periods. Further analysis of the company's overall debt profile, interest coverage ratio, and future debt repayment obligations would provide more insights into its financial health and risk profile.


Peer comparison

Dec 31, 2023


See also:

Johnson & Johnson Financial Leverage (Quarterly Data)